SELLAS Life Sciences Group Inc (SLS)
1.275
+0.04
(+2.82%)
USD |
NASDAQ |
May 01, 16:00
1.26
-0.02
(-1.18%)
After-Hours: 20:00
SELLAS Life Sciences Group Free Cash Flow (Quarterly): -4.825M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.825M |
| September 30, 2023 | -9.892M |
| June 30, 2023 | -10.07M |
| March 31, 2023 | -12.13M |
| December 31, 2022 | -5.152M |
| September 30, 2022 | -5.746M |
| June 30, 2022 | -10.26M |
| March 31, 2022 | -7.15M |
| December 31, 2021 | -4.976M |
| September 30, 2021 | -5.878M |
| June 30, 2021 | -4.898M |
| March 31, 2021 | -10.27M |
| December 31, 2020 | 3.424M |
| September 30, 2020 | -3.629M |
| June 30, 2020 | -3.381M |
| March 31, 2020 | -6.831M |
| December 31, 2019 | -4.176M |
| September 30, 2019 | -3.82M |
| June 30, 2019 | -4.656M |
| March 31, 2019 | -4.991M |
| December 31, 2018 | -4.555M |
| September 30, 2018 | -14.16M |
| June 30, 2018 | -6.299M |
| March 31, 2018 | -5.403M |
| December 31, 2017 | 15.25M |
| Date | Value |
|---|---|
| September 30, 2017 | -19.39M |
| June 30, 2017 | -3.049M |
| March 31, 2017 | -3.803M |
| December 31, 2016 | 25.07M |
| September 30, 2016 | -12.21M |
| June 30, 2016 | -11.49M |
| March 31, 2016 | -13.22M |
| December 31, 2015 | -15.36M |
| September 30, 2015 | -9.507M |
| June 30, 2015 | -11.88M |
| March 31, 2015 | -11.57M |
| December 31, 2014 | -10.84M |
| September 30, 2014 | -11.13M |
| June 30, 2014 | -13.28M |
| March 31, 2014 | -10.08M |
| December 31, 2013 | 1.817M |
| September 30, 2013 | -8.079M |
| June 30, 2013 | -7.57M |
| March 31, 2013 | -15.42M |
| December 31, 2012 | -5.178M |
| September 30, 2012 | -4.165M |
| June 30, 2012 | -6.745M |
| March 31, 2012 | -4.885M |
| December 31, 2011 | -4.169M |
| September 30, 2011 | -3.413M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-12.13M
Minimum
Mar 2023
3.424M
Maximum
Dec 2020
-6.016M
Average
-5.152M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Geron Corp | -41.00M |
| Immuneering Corp | -11.95M |
| Protagonist Therapeutics Inc | 16.94M |
| Akebia Therapeutics Inc | -2.308M |
| Moderna Inc | 402.00M |